REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

Also called NCT01381185

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 154 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01381185
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01381185. Non-randomized; no masking; primary purpose diagnostic. Start 2011-05 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
Acronym
REACT-MI
Condition
Acute Myocardial Infarction
Intervention (Drug)
Aspirin 200mg qd, Clopidogrel 2x75mg qd
Lead sponsor
University Hospital Ostrava (class: other)

Record details

Record id
cardio:ct-nct01381185
Content hash
c5e3c5149c6daea0533176168b3a4db9c3c05d4681ba08b7597a4b275bfc6567